PHARMACEUTICAL TECHNOLOGY III

Back

Learning Outcomes

Will be able to Evaluate Parenteral Dosage Forms.
• Repeats basic concepts and definitions in parenteral preparation. • Defines the term isotonia. • Discusses the importance of isotonic preparation in parenteral administration. • Recognizes isotonic solution preparation method. • Illustrates the isotonic solution preparation method. • Defines the term izohidri. • Discusses the importance of isohydric preparation in parenteral administration. • Defines the term sterility. • Defines the term pyrogen substance. • Defines intravenous [intravenous (i.v.)] administration. • Defines intramuscular [intramuscular (i.m.)] administration. • Defines the application between the skin [intracutaneous (i.c.) or intradermal (i.d.)]. • Defines subcutaneous (s.c.)] application under the skin. • Defines the inserted [intra-articular (i.a.)] application. • Defines the application to the subarachnoid region [intrathecal (i.t.)]. • Defines the application to the back and bottom of the brain [intrasisternal (i.s.)]. • Defines intra-cardiac [intracardiac] application. • Defines intraocular [intraocular] application. • It repeats local drug administration (rectal, vaginal, skin, eyes, nose, ear, inhalation) ways. • Identifies insert and implant. • Defines the dosage form for injection. • Discusses the superiority of the injectable dosage form. • Discusses the disadvantage of the injectable dosage form. Lists the way of injection dosage form. • Evaluates the parameters of the injection dosage form specific to the route of administration. • Defines injection volume for large volume. • Evaluates the properties of the large volume preparation for injection. • Defines small volume preparation for injection. • Evaluates the feature of the injection small volume preparation. • Defines the solution for injection. • Evaluates the property of the injectable solution. • Defines the injectable suspension. • Evaluates the feature of the injectable suspension. • Defines the emulsion for injection. • Evaluates the properties of the emulsion for injection. • Identifies reconstructed powder for injection. • Evaluates the property of the injected reconstituted powder. • Defines injectable concentrated liquid. • Evaluates the property of the concentrated liquid for injection. • Defines injection protein preparation. • Evaluates the feature of the injectable protein preparation. • Identifies the injected modified release system. • Evaluates the property of the injectable modified release system. • Defines peritoneal dialysis solution. • Describes hemodialysis solution. • Evaluates the feature that the injection formulation should have. • Discusses the parameters that are effective in the formulation for injection. • Defines the critical parameters of the active substance in the injection formulation. • Defines the critical parameters of the solvent in the formulation for injection. • Classifies the auxiliary substances used in the formulation for injection. • Illustrates the excipients used in the formulation for injection. • Defines the critical parameters of the excipient in the formulation for injection. • Evaluates injection formulation stages. Lists the isotony setting calculation of the dosage form for injection. • Illustrates the isotony setting calculation of the dosage form for injection. • Calculates isotonic solution using the freezing point lowering method. • Calculate isotonic solution using the White-Vincent method. • Calculates isotonic solution using sodium chloride equivalent method. • Calculates an isotonic solution using the millivival (mEq) method. • Calculates isotonic solution using Hammerland-Bjergard graphical method. • Describes the method of preparation of a large volume preparation for injection. • Describes the method of preparation of small-volume injection preparations. • Lists the steps for preparing solution for injection. Lists the stages of preparation for injection suspension. • Lists the steps for preparing emulsions for injection. Lists reconstructed powder preparation methods for injection. • Describes the lyophilization method for injection reconstituted powder. • Describes the spray drying method for reconstructed powder for injection. Lists the stages of preparation of concentrated liquid for injection. Lists the stages of preparation for the injection protein preparation. • Lists the system preparation steps that provide modified release for injection. • It controls the sterilization conditions of the injectable dosage form. • Recognizes the packaging materials used in the packaging of the injectable dosage form. • Describes the parameters to be considered in the packaging of the injection dosage form. Lists the quality control tests of the dosage form for injection. • Evaluates the quality control test results of the dosage form for injection. • Summarizes the stability problem in injectable solution. • Summarizes the stability problem seen in the injectable suspension. • Summarizes the stability problem in injectable emulsion. • Summarizes the stability problem seen in reconstituted powder for injection. • Summarizes the stability problem seen in the concentrated solution for injection. • Explains the importance of sterility testing in the form of injectable dosage. Lists sterility test methods in the dosage form for injection. • Explains the sterility test with different methods in the dosage form for injection. • Interprets the sterility test results in the form of injectable dosage. • Describes the sterility test in the form of injection dosage containing antibacterial active substance. Lists the sterilization methods of the injection dosage form. • Explains the importance of bacterial endotoxin test in the dosage form for injection. • Defines the Limulus Amebocyte Lysate Test (LAL test) for bacterial endotoxin measurement. • Explains the LAL test. • Explains the importance of pyrogenicity test. • Explains the performance of pyrogenicity test on rabbits. • Interprets the results of pyrogenicity test on rabbits.
Will be able to Evaluate Ophthalmic Dosage Form.
• Recognizes the anatomical structure of the eye. • Schematically expresses the anatomical structure of the eye. • Defines the cornea. • Schematically expresses the anatomical structure of the cornea. • Evaluates the role of the cornea in ocular absorption. • Explains the absorption of active substance via corneal route. • Describes the absorption of active substance non-corneally. Lists ophthalmic preparations. Lists the feature that the ophthalmic preparation should have. • Identifies ocular solution (eye drops; Ocula Guttae, Collyria). • Questions the features that the ocular solution should have. • Defines the eye bath. • Questions the features that the eye bath should have. • Defines ocular lotion. • Questions the features that the ocular lotion should have. • Defines ocular ointment. • Questions the features that the ocular ointment should have. • Identifies the ocular suspension. • Questions the features that the ocular suspension should have. • Defines ocular gel. • Queries the properties that the ocular gel should have. • Identifies reconstructed powder prepared for ocular application. • Questions the properties of the reconstituted powder prepared for ocular application. • Identifies the ocular insert. • Questions the features that the ocular insert should have. • Lists the modified release system prepared for the ocular application. • Defines the modified release system prepared for ocular application. • Illustrates the modified release system prepared for ocular application. • Questions the features of the modified release system prepared for ocular application. • Classifies the formulation components of the ophthalmic preparation. • Illustrates the formulation components of the ophthalmic preparation. • Lists the ocular route of administration. • Describes topical application. • Defines the periocular injection. • Defines intraocular injection (intracameral, intravitreal). • Defines retrobulbar injection. • Describes the ocular use of iontophoresis method. • Discusses the active substance localization in the ocular region with systemic application. • Lists the factors affecting active substance displacement in the precorneal region. • Evaluates the effect of tear production and tear circulation on active substance disposition. • Evaluates the effect of active substance protein interaction on active substance disposition. • Discusses the role of cornea in active substance displacement. • Defines ocular bioavailability. Lists the factors affecting ocular bioavailability. • Defines approaches to increase ocular bioavailability. • Discusses approaches to increase ocular bioavailability. Lists the sterilization methods of the ophthalmic preparation. • Discusses the criteria to be considered in the selection of the sterilization method of the ophthalmic preparation.
Will be able to Evaluate Sterilization.
• Identifies contamination. • Classifies sources of contamination. • Evaluates risk factors of contamination source. • Checks for particle contamination source. • Checks the source of microorganism contamination. • Defines sterilization. • Evaluates the sterilization kinetics. • Defines the 'D' value. • Defines the 'Z' value. • Defines the 'F' value. • Defines the inactivation factor (IF) value. • Makes the necessary calculations to determine the sterilization time. • Classifies sterilization methods. • Lists physical sterilization methods. Lists chemical sterilization methods. • Defines sterilization with saturated water vapor (wet heat; pressurized steam). • Lists the sterilization steps with saturated water vapor. • Evaluates the sterilization conditions with saturated water vapor. • It exemplifies the substance and preparation that can be sterilized with saturated water vapor. • Discusses the factors affecting sterilization with saturated water vapor. • Defines the 'autoclave' used in saturated water vapor sterilization. • Defines the Bowie Dick Test. • Evaluates Bowie Dick Test results. • Describes sterilization with dry hot air. • Lists the sterilization steps with dry hot air. • Evaluates the sterilization conditions with dry hot air. • Discusses the factors affecting sterilization with dry hot air. • It exemplifies the substance and preparation that can be sterilized with dry hot air. • Defines the 'oven and hot air tunnel' used in dry hot air sterilization. Lists process control methods in heat sterilization. • Explains the physical indicator in heat sterilization. • Explains the chemical indicator in heat sterilization. • Describes the biological indicator in heat sterilization. • Defines ray sterilization methods. • Defines UV sterilization. • Lists the sterilization steps with UV light. • Evaluates the sterilization conditions with UV light. • Discusses the factors affecting sterilization with UV light. • It exemplifies the substance and preparation that can be sterilized by UV light. • Recognizes the devices used in UV sterilization. • Defines sterilization with ionizing radiation. Lists the type of electromagnetic radiation used in sterilization with ionizing radiation. • Defines gamma ray sterilization. • Lists the type of particle radiation used in sterilization with ionizing radiation. • Defines sterilization with accelerated electron. • Lists the steps of sterilization with ionizing radiation. • Evaluates the sterilization conditions with ionizing radiation. • Discusses the factors affecting sterilization with ionizing radiation. • It exemplifies the substance and preparation that can be sterilized by ionizing radiation. • Recognizes the devices used in sterilization with ionizing radiation. • Defines sterilization by filtration. • Recognizes the filter material used in sterilization by filtration. • Lists the factors affecting sterilization by filtration. • Describes the steps of sterilization by filtration. • Evaluates the sterilization process control by filtration. • Illustrates the preparation that can be sterilized by filtration. • Defines chemical sterilization. Lists chemical sterilization methods. • Illustrates the gas used in chemical sterilization method. Lists the factors that affect the chemical sterilization method. • Defines sterilization with ethylene oxide. • Lists the factors affecting sterilization with ethylene oxide. • Describes the steps of sterilization process with ethylene oxide. • Shows the steps of sterilization process with ethylene oxide by drawing the diagram. • Evaluates sterilization process control with ethylene oxide. • Exemplifies the preparation that can be sterilized by the ethylene oxide sterilization method. • Defines the aseptic area. • Lists the properties that the aseptic area should have. • Interprets the properties of the aseptic area. • Evaluates working conditions in the aseptic field. • Interprets the need to work in the aseptic field. • Illustrates the preparation that should be prepared in the aseptic area. • Evaluates the air quality used in the aseptic area. • Schematically shows the aseptic area. • Aseptic field repeats the process steps. • Lists the filters used in the aseptic area. • Describes the properties of the filter used in the aseptic area. • Controls the process steps when working in the aseptic field. • Controls sterility control methods when working in aseptic field. • Repeats the in-process control in sterility control while working in the aseptic field. • When working in the aseptic field, the procedure repeats the process after sterility control. • Explains the 'bubble point' test performed in the filter while working in the aseptic field. • The HEPA filter used when working in an aseptic field describes the 'dioctyl phthalate' (DOP) test. • Defines sterilization validation. • Questions the importance of sterilization validation. • Plans the validation study specific to the sterilization method. • Controls the validation study specific to the sterilization method.
Will be able to Evaluate Powder Medicines.
• Defines powder medicine. • Classifies powder medicine. • Describes the preparation methods of powder medicine. • Describes the parameters to be considered in the preparation of powder medicine. • Determines the use of powder medicine. • Illustrates the packaging form of powder medicine. • Lists the control made in powder medicine. Lists the particle size analysis methods of powder medicine. • Summarizes the particle size analysis methods of powder medicine. • Evaluates the powder drug's particle size analysis results. • Evaluates the flow properties of powder medicine. • Explains the determination of bulk angle in powder medicine. • Evaluates the results of bulk angle determination in powder drug. • Defines the terms cluster density and stroke density in powder medicine. • Interprets the differences between cluster density and stroke density in powdered medicines. • Defines the 'Housner index' (HI) in powder medicine. • Interprets the acceptance limit of 'Housner index' (HI) in powder medicine. • Defines 'Carr index' in powder medicine. • Interprets the 'Carr index' acceptance limit in powder medicine. • Lists the points to be considered when mixing powders. • Evaluates problems that may be encountered in mixing powders. • Solves the problem that may be encountered in mixing powders. • Recognizes the packaging forms of powder medicine. Lists the packaging methods of powder medicine. • Names the properties that the powdered medicine package should bear. • Evaluates the problems that may be encountered in the packaging of powder medicine.
Will be able to Evaluate Micropellets.
• Identifies the micropellet. • Explains the preparation methods of the micropellet. • Evaluates the superiority of the micropellet. • Evaluates the inconvenience of the micropellet. • Lists the control performed on the microparticle.
Will be able to Prepare Parenteral Dosage Form
• Defines the parenteral dosage form. • Classifies the route of administration of the parenteral dosage form. • Classifies the parenteral dosage form according to its use. • Lists the issues to be considered in preparing the parenteral dosage form. • Defines the small volume injection solution. • Defines the large volume injection solution. • Lists the route of administration by solvent and carrier system. • Defines intravenous [intravenous (i.v.)] administration. • Defines intramuscular [intramuscular (i.m.)] administration. • Defines the application between the skin [intracutaneous (i.c.) or intradermal (i.d.)]. • Describes [subcutaneous (s.c.)] application under the skin. • Defines the inserted [intra-articular (i.a.)] application. • Defines the application of [intrathecal (i.t.)] to the subarachnoid region. • Defines the application to the back and bottom of the brain [intrasisternal (i.s.)]. • Defines intra-cardiac [intracardiac] application. • Defines intraocular [intraocular] application. • Explains how to dosing in parenteral dosage form. • Classifies the components in the form of parenteral dosage. • Defines water for injection. • Lists solvents that can be mixed with water. • Lists the bases that do not mix with water. • Lists preservatives in parenteral dosage form. • Identifies, classifies and samples antibacterial agent. • Identifies, classifies and exemplifies the antioxidant substance. • Identifies and exemplifies the cryoprotectant substance. • Defines izohidri. • Explains the importance of pH adjustment in the form of parenteral dosage. • Describes the pH adjustment in the form of parenteral dosage. • Classifies the substance and solvent used to adjust pH. • Describes the buffering capacity of the blood. • Defines tonicity and isotonic solution. • Explains the importance of isotonia in the form of parenteral dosage. • Defines the hypotonic solution. • Defines hemolysis. • Defines hypertonic solution. • Defines plasmolysis. • Defines and lists the heap agent. • Defines and lists suspension agent. • Defines and lists emulsion agent. • • Illustrates the isotony setting calculation of the dosage form for injection. • Calculates isotonia using the freezing point lowering method. • It calculates isotonia by using the White-Vincent method. • Calculates isotonia by using sodium chloride equivalent method. • Calculates isotonia by using the millivival method (mEq). • Calculates isotonia using Hammerland-Bjergard graphical method. • Explains the cleaning of ampoules and vials. • Explains rubber stopper cleaning. • Explains the cleaning of the aluminum cover. • Explains how to fill the bulb. • Describes the excess volume that should be placed in the fluid fluid according to the solution volume. • Describes the excess volume that should be placed in the viscous liquid according to the solution volume. Explain the reason and prevention of the carbonization of the ampoule. • Explains the packaging of the light decomposed preparation. • Makes the definition of sterilization. • Explains sterilization methods applied in laboratory conditions. • Explains the concept of sterilization table. • Lists what should be included in the sterilization table. • Defines sterilization with saturated water vapor (wet heat; pressurized steam). • Lists the sterilization steps with saturated water vapor. • Evaluates the sterilization conditions with saturated water vapor. • It exemplifies the substance and preparation that can be sterilized with saturated water vapor. • Discusses the factors affecting sterilization with saturated water vapor. • Defines the 'autoclave' used in saturated water vapor sterilization. • Describes sterilization with dry hot air. • Lists the sterilization steps with dry hot air. • Evaluates the sterilization conditions with dry hot air. • Discusses the factors affecting sterilization with dry hot air. • It exemplifies the substance and preparation that can be sterilized with dry hot air. • Defines the “oven and hot air tunnel” used in dry hot air sterilization. • Defines sterilization by filtration. • Recognizes the filter material used in sterilization by filtration. • Lists the factors affecting sterilization by filtration. • Describes the steps of sterilization by filtration. • Illustrates preparations that can be sterilized by filtration. • Describes the aseptic method. • Explain in-process inspection. • Classifies in-process audit. • Defines the examination of the process using the physical indicator. • Defines the examination of the process using the chemical indicator. • Defines the examination of the process using the biological indicator. • Explains post-transaction inspection. • Classifies post-processing inspection. • Classifies the control in the bulb. • Defines organoleptic control. • Defines optical control. • Defines the control and separation of the bulb containing carbonized residue. • Defines the process of determining the amount of drug contained in the unit packaging in volume. • Defines the process of controlling the number and size of particles. • Defines and implements the closing control. • Defines dose control. • Defines the sterility test. • Defines the pyrogenicity test. • Defines the concept of acidity. • Describes the steps of determining the degree of acidity. • Determines the degree of acidity. • Defines the injectable suspension. Lists the properties of the suspension for injection. • Defines the emulsion for injection. Lists the properties of the emulsion for injection. • Defines large volume parenteral preparation. • Classifies large volume parenteral preparation. • Defines the peritoneal dialysis solution. • Makes the definition of hemodialysis solution. • Describes the preparation of the Novaljin bulb. • Indicates the substance and its intended use in the composition of the Novaljin bulb. • Novaljin makes the necessary calculations for the preparation of the bulb. • Novaljin indicates the use of ampoule, intended use and label. • Prepares Novaljin bulbs and delivers them in suitable packaging. • Explains the preparation of procaine ampoules. • It indicates the substance and its intended use in the procaine ampoule composition. • Makes the necessary calculations for the preparation of procaine ampoules. • Procaine ampoule indicates the usage, purpose and label. • It prepares procaine ampoules and delivers them in appropriate packaging. • Explains the preparation of Vitamin C ampoules. • Indicates the substance and its intended use in Vitamin C ampoule composition. • Makes the necessary calculations for the preparation of Vitamin C ampoules. • Vitamin C indicates the use of ampoules, the purpose and label of use. • Prepares Vitamin C ampoules and delivers them in appropriate packaging. • Explains the preparation of glucose ampoules. • It indicates the substance and its intended use in the composition of the glucose ampoule. • Makes the necessary calculations for the preparation of glucose ampoules. • Glucose ampoule indicates the usage, purpose and label. • Prepares glucose ampoules and delivers them in appropriate packaging. • Explains the preparation of sterile neutral olive oil. • Indicates the substance and its intended use in sterile neutral olive oil composition. • Makes the necessary calculations for the preparation of sterile neutral olive oil. • Indicates the usage of sterile neutral olive oil, its purpose and label. • Prepares sterile neutral olive oil and delivers in appropriate packaging. • Explains the preparation of Vitamin D3 ampoules. • Indicates the substance and its intended use in Vitamin D3 ampoule composition. • Makes the necessary calculations for the preparation of Vitamin D3 ampoules. • Vitamin D3 indicates the type of use, the purpose and the label of the ampoule. • Prepares Vitamin D3 ampoules and delivers them in appropriate packaging. • Explains the preparation of peritoneal dialysis solution. • It indicates the substance and its intended use in the composition of peritoneal dialysis solution. • Makes the necessary calculations for the preparation of peritoneal dialysis solution. • Peritoneal dialysis solution indicates usage, purpose and label. • Prepares peritoneal dialysis solution and delivers it in appropriate packaging. • Describes the preparation of hemodialysis solution. • Indicates the substance and its intended use in the composition of hemodialysis solution. • Makes the necessary calculations for the preparation of hemodialysis solution. • Hemodialysis solution indicates usage method, usage purpose and label. • Prepares hemodialysis solution and delivers it in appropriate packaging.
Will be able to Prepare Ophthalmic Dosage Forms
• Defines ophthalmic dosage form. • Classifies the ophthalmic dosage form. • Lists the properties that the ophthalmic dosage form should bear. • Identifies ocular solution (eye drops; ocula guttae, collyria). • Questions the features that the ocular solution should have. • Describes the preparation of ophthalmic solution containing potassium iodide. • Indicates the substance and its intended use in the ophthalmic solution composition containing potassium iodide. • Makes the necessary calculations for the preparation of ophthalmic solution containing potassium iodide. • Indicates the use, purpose and label of the ophthalmic solution containing potassium iodide. • Prepares an ophthalmic solution containing potassium iodide and delivers it in appropriate packaging. • Describes the preparation of ophthalmic solution containing zinc sulfate. • Indicates the substance and its intended use in the ophthalmic solution composition containing zinc sulfate. • Makes the necessary calculations for the preparation of ophthalmic solution containing zinc sulfate. • Indicates the type of ophthalmic solution containing zinc sulfate, its purpose and label. • Prepares ophthalmic solution containing zinc sulfate and delivers in appropriate packaging. • Explains the preparation of ophthalmic solution containing pilocarpine nitrate. • Indicates the substance and its intended use in ophthalmic solution composition containing pilocarpine nitrate. • Makes the necessary calculations for the preparation of ophthalmic solution containing pilocarpine nitrate. • Indicates the use, purpose and label of the ophthalmic solution containing pilocarpine nitrate. • Prepares ophthalmic solution containing pilocarpine nitrate and delivers it in suitable packaging. • Describes the preparation of ophthalmic solution containing atropine sulfate. • Indicates the substance and its intended use in ophthalmic solution composition containing atropine sulfate. • Makes the necessary calculations for the preparation of ophthalmic solution containing atropine sulfate. • Indicates the use, purpose and label of the ophthalmic solution containing atropine sulfate. • It prepares ophthalmic solution containing atropine sulfate and delivers in appropriate packaging. • Describes the preparation of ophthalmic solution containing boric acid. • Indicates the substance and its intended use in ophthalmic solution composition containing boric acid. • Makes the necessary calculations for the preparation of ophthalmic solution containing boric acid. • Indicates the use, purpose and label of the ophthalmic solution containing boric acid. • Prepares ophthalmic solution containing boric acid and delivers in appropriate packaging. • Explains the preparation of ophthalmic solution containing borax. • Indicates the substance and its intended use in ophthalmic solution composition containing borax. • Makes the necessary calculations for the preparation of ophthalmic solution containing borax. • Indicates the use, purpose and label of the ophthalmic solution containing borax. • Prepares ophthalmic solution containing borax and delivers in appropriate packaging.
Will be able to Prepare Nose and Ear Drops.
• Defines nasal drops. • Lists the features that nose drops should have. • Describes the preparation of nasal drops containing ephedrine hydrochloride-methyl cellulose. • Indicates the substance and its intended use in nasal drop composition containing ephedrine hydrochloride-methyl cellulose. • Makes the necessary calculations for the preparation of nasal drops containing ephedrine hydrochloride-methyl cellulose. • It specifies the usage, purpose and label of nasal drops containing ephedrine hydrochloride-methyl cellulose. • Prepares nasal drops containing ephedrine hydrochloride-methyl cellulose and delivers them in appropriate packaging. • Describes the preparation of nasal drops containing ephedrine hydrochloride. Indicates the substance and its intended use in the composition of nasal drops containing ephedrine hydrochloride. • Makes the necessary calculations for the preparation of nasal drops containing ephedrine hydrochloride. • It specifies the use, purpose and label of nasal drops containing ephedrine hydrochloride. • Prepares nasal drops containing ephedrine hydrochloride and delivers them in appropriate packaging. • Defines ear drops. • Lists the features that ear drops should have. • 'Glycerine phenique' describes the preparation of ear drops. • 'Glycerine phenique' refers to the substance and its intended use in the composition of ear drops. • The 'Glycerine phenique' makes the necessary calculations for the preparation of ear drops. • 'Glycerine phenique' specifies the type of use of the ear drops, the purpose of use and the label. • Prepares 'Glycerine phenique' ear drops and delivers them in appropriate packaging. • Describes the preparation of ear drops containing benzocaine. Indicates the substance and its intended use in the composition of ear drops containing benzocaine. • Makes the necessary calculations for the preparation of ear drops containing benzocaine. • It specifies the usage, purpose and label of use of ear drops containing benzocaine. • Prepares ear drops containing benzocaine and delivers them in appropriate packaging.
Will be able to Evaluate Cachet and Pilule Dosing Forms.
• Makes the cachet definition. Lists the properties that the cachet formulation should have. • Explains the purposes of using the cachet formulation. • Explains filling the cachet. • Lists the cachet number. • Determines the amount of dust it receives according to the cachet number. • Defines the pilule. • Lists the properties that the pilule formulation should bear. • Lists the processes of preparing the formulation of the pilule. • Gives an example of anti-stick powder.
Will be able to Prepare Package Type Preparation
• Makes the definition of package. • Lists the properties of the package formulation. • Defines the package formulation containing narcotic substance. Lists the issues to be considered in the package formulation containing narcotic substance • Explain the packaging of the package formulation. • Describes the preparation of the package containing papaverine hydrochloride. • Indicates the substance and its intended use in the package composition containing papaverine hydrochloride. • Makes the necessary calculations for the preparation of the package containing papaverine hydrochloride. • It specifies the usage, purpose and label of the package containing papaverine hydrochloride. • Papaverine prepares a package containing hydrochloride and delivers it in an appropriate package. • Explains the preparation of the package containing menthol. • Indicates the substance and its intended use in the package composition containing menthol. • Makes the necessary calculations for the preparation of the package containing menthol. • It specifies the usage, the purpose and the label of the package containing menthol. • Prepares a package containing menthol and delivers it in an appropriate package
Will be able to Prepare Hard Capsul.
• Defines hard capsule. • Lists the properties of the hard capsule formulation. • Lists the hard capsule formulation preparation processes. • Explains the hard capsule number and the amount of dust it receives. • Selects the appropriate hard capsule size according to the density of the powder mass to be filled. • Defines the control of weight equivalence in the capsule. • Describes the preparation of hard capsules containing menthol. • Indicates the substance and its intended use in hard capsule composition containing menthol. • Makes the necessary calculations for the preparation of hard capsules containing menthol. • It specifies the usage, purpose and label of the hard capsule containing menthol. • It prepares hard capsules containing menthol and delivers them in appropriate packaging. • Explains the preparation of hard capsules containing theophylline. • Indicates the substance and its intended use in hard capsule composition containing theophylline. • Makes the necessary calculations and dose calculations for the preparation of hard capsules containing theophylline. • Indicates the usage, purpose and label of the hard capsule containing theophylline. • It prepares hard capsules containing theophylline and delivers them in appropriate packaging.